Introduction: Given the vulnerability of chronic kidney disease individuals to SARS-CoV-2, nephrology societies have issued statements calling for prioritization of these patients for vaccination. It is not yet known whether COVID-19 vaccines grant the same high level of protection in patients with kidney disease compared to the non-dialysis population. The aims of this study were to evaluate the safety - measured by the adverse events potentially attributed to vaccines (ESAVI) - and the effectiveness - evaluated by the presence of antibodies - in dialysis patients immunized with the COVID-19 Sputnik V vaccine.
View Article and Find Full Text PDFObjective: To describe the perceptions of renal transplant patients of the need for information about their donors and the potential influence of their donors' biological sex and age.
Materials And Methods: Analytical, observational, cross-sectional and prospective study. Kidney transplant patients over 18 years old who had been transplanted, at least, one year before were included.
Background: The worldwide seroprevalence of human BK polyomavirus (BKV) in adults is 80%. About 10%-60% of renal transplant recipients experience BKV infection, nephropathy of the graft may occur in 5% of the cases, and up to 45% lose the graft. The aim of this work was to describe the prevalence of BK viruria during the 1st year after transplantation.
View Article and Find Full Text PDFIntroduction: The Argentine Society of Transplants has set in motion an activity called Grand Rounds to Provide Feedback on Procurement Activities with the purpose of informing, training, and creating awareness by providing information about the evolution of transplanted patients.
Objective: To measure, describe and analyze the impact that the transplant results presented at the rounds had on participants.
Results: One hundred and fifty-eight surveys were conducted.